Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/26/2024 | $6.50 → $1.25 | Overweight → Equal-Weight | Morgan Stanley |
| 1/3/2024 | $8.00 | Underweight | Barclays |
| 12/20/2023 | $14.00 | Buy | Guggenheim |
| 9/27/2023 | $4.00 → $10.00 | Sell → Hold | Craig Hallum |
| 7/26/2023 | $5.00 → $13.00 | Equal-Weight → Overweight | Morgan Stanley |
| 4/11/2023 | $3.80 → $13.00 | Neutral → Buy | Goldman |
| 3/8/2023 | $4.00 | Hold → Sell | Craig Hallum |
| 3/3/2022 | $30.00 → $20.00 | Buy | DA Davidson |
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers" or the "Company"), the global leader in science-backed weight management, announced that it will host an investor conference call today May 6, 2025, at 6:00 p.m. ET. During the call, Tara Comonte, President and Chief Executive Officer, and Felicia DellaFortuna, Chief Financial Officer, will discuss an agreement with the Company's lenders and noteholders that will significantly reduce debt obligations that is currently expected to result in a voluntary prepackaged filing under Chapter 11 of the U.S. Bankruptcy Code. The webcast of the conference call will be available on the Company's corporate w
Fourth Quarter 2024 Financial Highlights Total End of Period Subscribers of 3.3 million, including 92 thousand End of Period Clinical SubscribersRevenues of $184.4 million; Subscription Revenues down 7.3% vs. prior year period, including Clinical Subscription Revenues of $20.5 million, up 57.9% vs. prior year periodGross Margin of 69.7%, up 906 basis points vs. prior year period; Adjusted Gross Margin of 69.1%, up 771 basis points vs. prior year periodOperating Income of $36.2 million; Operating Income Margin of 19.6%, up 2,256 basis points vs. prior year period; Adjusted Operating Income of $36.9 million; Adjusted Operating Income Margin of 20.0%, up 967 basis points vs. prior year periodN
NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers," "WW," or the "Company") will release its results for the fourth quarter and full year 2024 ended December 28, 2024, after market close on Thursday, February 27, 2025. WeightWatchers will host a conference call at 5:00 p.m. ET the same day. During the conference call, Tara Comonte, Interim President and Chief Executive Officer, and Felicia DellaFortuna, Chief Financial Officer, will discuss the fourth quarter and full year 2024 results and answer questions from the investment community. The live webcast of the conference call will be available on the Company's corporate website, corporate.ww.
Morgan Stanley downgraded WW from Overweight to Equal-Weight and set a new price target of $1.25 from $6.50 previously
Barclays initiated coverage of WW with a rating of Underweight and set a new price target of $8.00
Guggenheim resumed coverage of WW with a rating of Buy and set a new price target of $14.00
SC 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)
SC 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)
SC 13G - WW INTERNATIONAL, INC. (0000105319) (Subject)
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers," "WW," or the "Company") today announced the appointment of Felicia DellaFortuna as Chief Financial Officer, effective January 1, 2025. She succeeds Heather Stark, who will remain with the Company through December 27, 2024. "We are thrilled to welcome Felicia DellaFortuna as our new Chief Financial Officer at this pivotal time for WeightWatchers," said Tara Comonte, Interim Chief Executive Officer. "Felicia brings extensive experience in strategic financial leadership, operational excellence, and enterprise value creation that will be instrumental as we navigate this critical period of tra
Independent Board Member Tara Comonte Will Serve as Interim Chief Executive OfficerSima Sistani Will Step Down as CEO and Director NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers," "WW," or the "Company") announced today that WeightWatchers Board member Tara Comonte has been appointed Interim Chief Executive Officer. Ms. Comonte succeeds Sima Sistani, who departs from her role as Chief Executive Officer and as a member of the Board, effective today. During her tenure, Ms. Sistani led the Company's transformation to a modern digital health organization and extended the Company's portfolio of solutions into the telehealth space with the acqu
NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ:WW), ("WeightWatchers," "WW," or the "Company") announced today the appointments of Scott Honken as Chief Commercial Officer and Phillip Picardi as Chief Impact Officer. The two will collaborate, alongside the existing leadership team to redefine community engagement across all stakeholders, including a continued focus on B2B constituents of employers, payers, and health plans and expanding access through WeightWatchers for Business. "Scott and Phillip will propel us forward as we embark upon a new chapter of growth for WeightWatchers," said Sima Sistani, CEO WeightWatchers. "Their expertise engaging communities and accel
Operations continue with no impact to its more than three million members worldwide Positions the Company to execute its transformation strategy, focused on enhancing its digital and member experience and expanding its telehealth business which achieved 57% year-over-year revenue growth in Q1 2025 Enters comprehensive agreement with lenders and noteholders to significantly reduce its debt obligations and bolster financial flexibility Expects reorganization plan to be confirmed in approximately 40 days and to emerge as a publicly traded company NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- WW International, Inc., the global leader in science-backed weight management, and
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers" or the "Company"), the global leader in science-backed weight management, announced that it will host an investor conference call today May 6, 2025, at 6:00 p.m. ET. During the call, Tara Comonte, President and Chief Executive Officer, and Felicia DellaFortuna, Chief Financial Officer, will discuss an agreement with the Company's lenders and noteholders that will significantly reduce debt obligations that is currently expected to result in a voluntary prepackaged filing under Chapter 11 of the U.S. Bankruptcy Code. The webcast of the conference call will be available on the Company's corporate w
Total End of Period Subscribers of 3.4 million, including 135 thousand End of Period Clinical SubscribersRevenues of $186.6 million, down 9.7% vs. prior year period, including Clinical Subscription Revenues of $29.5 million, up 57.1% vs. prior year periodSubscription Revenues Per Paid Weeks up 4.8% vs. prior year periodGross Margin of 71.2%, up 450 basis points vs. prior year period; Adjusted Gross Margin of 71.0%, up 311 basis points vs. prior year periodNet Loss of $72.6 million; Net Loss Margin of 38.9%, improved from Net Loss Margin of 168.4% in the prior year period; Adjusted EBITDAS of $26.9 million; Adjusted EBITDAS Margin of 14.4%, up from Adjusted EBITDAS Margin of 3.5% in the prior
4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)
8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)
10-Q - WW INTERNATIONAL, INC. (0000105319) (Filer)
4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
3 - WW INTERNATIONAL, INC. (0000105319) (Issuer)